BioXcel Therapeutics Inc (BTAI): Next-Year EPS Estimate 27.07%
As of 2026-04-23, BioXcel Therapeutics Inc (BTAI) has a next-year EPS growth estimate of 27.07%.
On 2026-04-01, analyst consensus for BTAI's next-year EPS growth shifted from 59.57% to 27.07% — a negative change of 32.50 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at 60.51%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 27.07%
- EPS growth this year
- 60.51%
- EPS next quarter (est)
- -$0.62
- Last price
- $1.10
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-04-23 | 27.07% | 60.51% | -$0.62 | $1.10 |
| 2026-04-22 | 27.07% | 60.51% | -$0.62 | $1.15 |
| 2026-04-21 | 27.07% | 60.51% | -$0.62 | $1.15 |
| 2026-04-20 | 27.07% | 60.51% | -$0.62 | $1.20 |
| 2026-04-19 | 27.07% | 60.51% | -$0.62 | $1.15 |
| 2026-04-16 | 27.07% | 60.51% | -$0.62 | $1.07 |
| 2026-04-15 | 27.07% | 60.51% | -$0.62 | $1.05 |
| 2026-04-14 | 27.07% | 60.51% | -$0.62 | $1.06 |
| 2026-04-13 | 27.07% | 60.51% | -$0.62 | $1.02 |
| 2026-04-12 | 27.07% | 60.51% | -$0.62 | $1.06 |
| 2026-04-10 | 27.07% | 60.51% | -$0.62 | $1.08 |
| 2026-04-09 | 27.07% | 60.51% | -$0.62 | $1.08 |
| 2026-04-08 | 27.07% | N/A | -$0.62 | $1.10 |
| 2026-04-07 | 27.07% | N/A | -$0.62 | $1.09 |
| 2026-04-06 | 27.07% | N/A | -$0.62 | $1.09 |
| 2026-04-05 | 27.07% | N/A | -$0.62 | $1.18 |
| 2026-04-03 | 27.07% | N/A | -$0.62 | $1.09 |
| 2026-04-02 | 27.07% | N/A | -$0.62 | $1.09 |
| 2026-04-01 | 27.07% | N/A | -$0.62 | $1.09 |
| 2026-03-27 | 59.57% | N/A | N/A | $1.26 |
| 2026-03-26 | 59.57% | N/A | N/A | $1.37 |
| 2026-03-26 | 59.57% | N/A | N/A | $1.37 |
| 2026-03-26 | 59.57% | N/A | N/A | $1.37 |
| 2026-03-25 | 59.57% | N/A | N/A | $1.43 |
| 2026-03-25 | 59.57% | N/A | N/A | $1.43 |
| 2026-03-25 | 59.57% | N/A | N/A | $1.43 |
| 2026-03-24 | 59.57% | N/A | N/A | $1.43 |
| 2026-03-24 | 59.57% | N/A | N/A | $1.43 |
| 2026-03-24 | 59.57% | N/A | N/A | $1.43 |
| 2026-03-23 | 59.57% | N/A | N/A | $1.47 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is BioXcel Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-04-23, BioXcel Therapeutics Inc (BTAI) has a next-year EPS growth estimate of 27.07%, based on analyst consensus.
When was the latest EPS estimate revision for BTAI?▾
The most recent revision occurred on 2026-04-01, when analysts adjusted the next-year EPS growth estimate from 59.57% to 27.07%.
What sector and industry does BioXcel Therapeutics Inc belong to?▾
BioXcel Therapeutics Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BTAI appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. BioXcel Therapeutics Inc (BTAI) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports